Jessica Fye

Work

Analyst Jessica Fye works at JPMORGAN and is focused on the Healthcare sector with 302 price targets and ratings documented since 2012 spanning on 27 stocks. Analyst's average stock valuation to be materialised ratio is 64.1% with an average time for price targets to be met of 142.74 days.

Most recent stock forecast was given on HALO, Halozyme Therapeutics, Inc at 22-Nov-2022.

Jessica Fye best performing recommendations are on ESPR (ESPERION THERAPEUTICS, INC).
The best stock recommendation documented was for ESPR (ESPERION THERAPEUTICS, INC) at 5/3/2018. The price target of $41 was fulfilled within 1 day with a profit of $4.07 (11.02%) receiving and performance score of 110.21.

Average potential price target upside

AMRN ARNA ASND BCRX CARA CRNX DNLI EBS ESPR HALO IMGN ITCI JAZZ LABP MGTA NKTR STOK TCDA UTHR IONS KLDO LXRX RDUS APTX MIRM DCPH LVTX
AMRN ARNA ASND BCRX CARA CRNX DNLI EBS ESPR HALO IMGN ITCI JAZZ LABP MGTA NKTR STOK TCDA UTHR IONS KLDO LXRX RDUS APTX MIRM DCPH LVTX